Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:Q9UIJ5 (
Rec
)
58,342
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Intramuscular injections of 4 or 8 mg
25-hydroxycholecalciferol
(25-OH D3) in 5 ml corn oil given three days before the predicted calving date and repeated at weekly intervals until calving effectively reduced the incidence of parturient paresis. Drug efficacy was improved in cows receiving low to normal recommended levels of dietary phosphorus prepartum. With proper management techniques, 25-OH D3 could prevent parturient paresis in dairy cattle.
Vet
Rec
1978 Aug 12
PMID:25-hydroxycholecalciferol for prevention of "milk fever" in dairy cows. 69 55
The effects of providing ultraviolet (uv) radiation (285 to 315 nm, ultraviolet B) on calcium metabolism in two groups of 20 healthy grey parrots (Psittacus e erithacus) fed either a seed or pellet-based diet were investigated. There was a significant increase in the concentration of ionised calcium in the plasma of both groups, independent of the calcium and vitamin D(3) content of the diets fed, and a significant increase in the plasma concentration of
25-hydroxycholecalciferol
in only the seed-fed group. In a separate study there were no significant increases in plasma ionised calcium or
25-hydroxycholecalciferol
between March and August in a group of 28 South American parrots (Pionus species) exposed to unfiltered natural sunlight.
Vet
Rec
2006 Aug 19
PMID:Effects of UVB radiation on calcium metabolism in psittacine birds. 1692 Oct 12
The plasma concentration of
25-hydroxycholecalciferol
was measured in 13 adult Hermann's tortoises (Testudo hermanni), seven adult spur-thighed tortoises (Testudo graeca) and two adult marginated tortoises (Testudo marginata) during 2004. They were healthy, of both sexes, and kept in captivity under natural unfiltered sunlight in southern England with no dietary sources of cholecalciferol. Blood samples were taken in March, June and August, and the concentration of
25-hydroxycholecalciferol
did not vary significantly with the seasons. However, the concentrations in the female tortoises were always significantly lower than in the males.
Vet
Rec
2008 Mar 15
PMID:Plasma concentrations of 25-hydroxycholecalciferol in 22 captive tortoises (Testudo species). 1834 99
Atopic dermatitis (AD) in dogs is among the most common skin diseases in small animal practice. It is an inflammatory disease based on a genetic predisposition to develop hypersensitivity against environmental and food allergens and typical clinical signs up exposure. Treatment sometimes can be difficult and associated with adverse effects. Previous studies evaluating cholecalciferol as treatment for human AD have shown promising results. With canine AD being a good animal model for its human counterpart, it was hypothesised that cholecalciferol might have beneficial clinical effects in dogs, too. In this randomised, placebo-controlled, double-blinded eight-week cross-over study, 23 client-owned dogs received either systemic cholecalciferol (n=16), a vitamin D receptor analogue (n=8) or placebo (n=13). Blood samples for ionised calcium were obtained regularly during the study, and Canine Atopic Dermatitis Extent and Severity Index and pruritus scores, blood levels of vitamin D metabolites, measurements of skin pH and transepidermal water loss were determined before and after. Pruritus and lesion scores decreased significantly in the cholecalciferol group versus placebo. No differences in water loss or skin pH were observed. An increase in serum
25-hydroxycholecalciferol
strongly correlated with a reduction in pruritus. Systemic cholecalciferol may be a viable treatment option for canine AD.
Vet
Rec
2018 04 07
PMID:Vitamin D shows in vivo efficacy in a placebo-controlled, double-blinded, randomised clinical trial on canine atopic dermatitis. 2962 36